IRIS UniCatt

Bientinesi, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.536
NA - Nord America 2.787
AS - Asia 2.006
SA - Sud America 362
AF - Africa 71
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.680
IT - Italia 1.842
SG - Singapore 900
DE - Germania 438
CN - Cina 414
SE - Svezia 321
BR - Brasile 293
FR - Francia 258
VN - Vietnam 201
UA - Ucraina 181
GB - Regno Unito 116
IN - India 109
IE - Irlanda 79
JP - Giappone 76
NL - Olanda 71
ID - Indonesia 59
HK - Hong Kong 51
CA - Canada 50
RU - Federazione Russa 50
FI - Finlandia 43
MX - Messico 31
BD - Bangladesh 29
AR - Argentina 28
PL - Polonia 28
KR - Corea 26
BE - Belgio 25
ZA - Sudafrica 23
ES - Italia 22
IQ - Iraq 22
TR - Turchia 20
CH - Svizzera 14
EG - Egitto 14
EC - Ecuador 11
PH - Filippine 11
PK - Pakistan 11
AT - Austria 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
IR - Iran 9
MY - Malesia 8
VE - Venezuela 8
CL - Cile 7
HU - Ungheria 7
MA - Marocco 7
CR - Costa Rica 6
AU - Australia 5
CZ - Repubblica Ceca 5
LT - Lituania 5
PE - Perù 5
UZ - Uzbekistan 5
CO - Colombia 4
HN - Honduras 4
LK - Sri Lanka 4
NP - Nepal 4
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BZ - Belize 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
MM - Myanmar 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MN - Mongolia 1
Totale 8.764
Salva come PNG Salva come JPEG
Città #
Singapore 500
Chandler 365
Ashburn 307
Rome 301
San Jose 243
Milan 178
Ann Arbor 97
Beijing 95
Los Angeles 86
Jacksonville 80
New York 79
Dublin 78
The Dalles 74
Ho Chi Minh City 69
San Mateo 64
Jakarta 55
Lauterbourg 54
Hanoi 50
Wilmington 47
Frankfurt am Main 46
Florence 45
Hefei 45
Hong Kong 42
Tokyo 39
Nanjing 37
Naples 37
Munich 36
São Paulo 33
Kadoma 28
Houston 25
Moscow 25
Nanchang 25
Woodbridge 25
Bari 24
Dearborn 24
Hyderabad 24
Boston 23
Seattle 22
Bremen 21
Brussels 21
Cattolica 21
Lawrence 21
Bologna 20
Dallas 20
Toronto 20
Buffalo 19
Chicago 19
Johannesburg 19
Redwood City 18
Seoul 18
Verona 18
Denver 17
Santa Clara 17
Stockholm 17
Marseille 16
Turin 16
Catania 15
Düsseldorf 15
Mountain View 15
Palermo 15
Princeton 15
Fairfield 14
London 14
Warsaw 14
Atlanta 13
Council Bluffs 13
Da Nang 13
Kent 13
Lancaster 13
Montreal 13
Nürnberg 12
Orem 12
Paris 12
Redmond 12
Cagliari 11
Cairo 11
Chennai 11
San Francisco 11
Washington 11
Poplar 10
Sesto Fiorentino 10
Abidjan 9
Amsterdam 9
Baghdad 9
Baku 9
Boardman 9
Menlo Park 9
Padova 9
Saint Petersburg 9
Charlotte 8
Genoa 8
Helsinki 8
Manchester 8
Mexico City 8
Rio de Janeiro 8
Augusta 7
Belo Horizonte 7
Bexley 7
Brooklyn 7
Kuala Lumpur 7
Totale 4.238
Salva come PNG Salva come JPEG
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.221
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 943
Le infezioni delle vie urinarie 252
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 203
The occult urothelial cancer 199
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 188
[Overactive bladder syndrome: the social and economic perspective] 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 168
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 168
Bladder and prostate metastasis from small cell lung cancer: a rare entity 167
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 163
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 161
Antibiotic prophylaxis in urology 160
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 156
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 149
Methylation study of the Paris system for reporting urinary (TPS) categories 134
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 130
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 130
The occult urothelial cancer 130
Current status of robotic urologic surgery in Italy 129
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 126
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 122
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 119
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 118
Double J stent migration in the contralateral ureter during robotassisted pyeloplasty: an unique complication 118
Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review 116
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 114
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 114
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 113
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 111
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 111
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 108
Retigabine induces relaxations of the human bladder detrusor 107
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 105
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 98
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 97
Lifestyle in urology: Cancer 97
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 96
Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature 95
What can the metaverse do for urology? 93
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 93
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 92
Managing urinary incontinence in women - a review of new and emerging pharmacotherapy 91
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 90
Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences 88
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 86
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 86
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 80
Managing urological disorders in multiple sclerosis patients: A review of available and emerging therapies 75
Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline? 70
Mirabegron: A review of recent data and its prospects in the management of overactive bladder 64
Totale 8.868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 0 75 20
2021/2022545 52 27 30 52 45 32 17 60 41 40 57 92
2022/20231.109 132 138 90 177 71 120 60 101 125 21 39 35
2023/20241.145 66 147 79 102 67 90 76 129 68 96 86 139
2024/20251.606 71 67 124 65 140 91 98 74 205 179 271 221
2025/20262.805 389 101 158 338 561 152 567 153 177 181 28 0
Totale 8.868